| Primary |
| Dementia Alzheimer's Type |
60.6% |
| Dementia |
8.3% |
| Product Used For Unknown Indication |
6.6% |
| Hypertension |
3.8% |
| Depression |
3.5% |
| Parkinson's Disease |
3.5% |
| Hypothyroidism |
1.4% |
| Insomnia |
1.4% |
| Pain |
1.4% |
| Anxiety |
1.0% |
| Behavioural And Psychiatric Symptoms Of Dementia |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hyperlipidaemia |
1.0% |
| Memory Impairment |
1.0% |
| Urinary Tract Infection |
1.0% |
| Abdominal Pain Upper |
0.7% |
| Addison's Disease |
0.7% |
| Agitation |
0.7% |
| Bipolar Ii Disorder |
0.7% |
| Cardiovascular Event Prophylaxis |
0.7% |
|
| Death |
29.8% |
| Syncope |
8.5% |
| Vomiting |
7.4% |
| Aggression |
4.3% |
| Rash |
4.3% |
| Speech Disorder |
4.3% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Condition Aggravated |
3.2% |
| Convulsion |
3.2% |
| Dyskinesia |
3.2% |
| Fall |
3.2% |
| Fracture |
3.2% |
| General Physical Health Deterioration |
3.2% |
| Hepatic Function Abnormal |
3.2% |
| Loss Of Consciousness |
3.2% |
| Nausea |
3.2% |
| Panic Attack |
3.2% |
| Activities Of Daily Living Impaired |
2.1% |
| Adrenal Insufficiency |
2.1% |
| Atrioventricular Block Complete |
2.1% |
|
| Secondary |
| Dementia Alzheimer's Type |
39.2% |
| Hypertension |
10.0% |
| Osteoporosis Postmenopausal |
5.8% |
| Parkinson's Disease |
5.8% |
| Dementia |
5.1% |
| Product Used For Unknown Indication |
5.1% |
| Accidental Exposure |
3.2% |
| Prophylaxis |
3.2% |
| Drug Use For Unknown Indication |
2.6% |
| Multiple Myeloma |
2.6% |
| Depression |
2.3% |
| Diabetes Mellitus |
2.3% |
| Behavioural And Psychiatric Symptoms Of Dementia |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Osteoporosis |
1.9% |
| Type 2 Diabetes Mellitus |
1.9% |
| Addison's Disease |
1.3% |
| Epilepsy |
1.3% |
| Hallucination |
1.3% |
| Medical Diet |
1.3% |
|
| Vomiting |
12.5% |
| Infection |
7.5% |
| Nausea |
7.5% |
| Speech Disorder |
6.3% |
| Syncope |
6.3% |
| Death |
5.0% |
| Fracture |
5.0% |
| Insomnia |
5.0% |
| Sleep Talking |
5.0% |
| Urinary Incontinence |
5.0% |
| Application Site Dermatitis |
3.8% |
| Cardiac Failure |
3.8% |
| Drug Ineffective |
3.8% |
| Fall |
3.8% |
| Hepatic Function Abnormal |
3.8% |
| Oedema Peripheral |
3.8% |
| Pneumonia |
3.8% |
| Rales |
3.8% |
| Abnormal Behaviour |
2.5% |
| Application Site Discolouration |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.3% |
| Parkinson's Disease |
11.0% |
| Drug Use For Unknown Indication |
8.3% |
| Hypertension |
6.0% |
| Dementia Alzheimer's Type |
5.5% |
| Dementia |
5.1% |
| Schizophrenia |
5.1% |
| Depression |
4.4% |
| Psychotic Disorder |
3.9% |
| Dementia With Lewy Bodies |
3.7% |
| Agitation |
3.4% |
| Anxiety |
3.2% |
| Senile Dementia |
3.2% |
| Pain |
2.8% |
| Hallucination |
2.5% |
| Osteoporosis |
2.3% |
| Constipation |
2.1% |
| Atrial Fibrillation |
1.8% |
| Prophylaxis |
1.8% |
| Insomnia |
1.6% |
|
| Malaise |
9.6% |
| Wound |
8.2% |
| Death |
6.8% |
| Tremor |
6.8% |
| Hallucination |
5.5% |
| Lower Respiratory Tract Infection |
5.5% |
| Neuroleptic Malignant Syndrome |
5.5% |
| Pleurothotonus |
5.5% |
| Hypotension |
4.1% |
| International Normalised Ratio Increased |
4.1% |
| Large Intestine Perforation |
4.1% |
| Motor Dysfunction |
4.1% |
| Parkinson's Disease |
4.1% |
| Pneumonia Aspiration |
4.1% |
| Rash |
4.1% |
| Somnolence |
4.1% |
| Toothache |
4.1% |
| Vomiting |
4.1% |
| Apathy |
2.7% |
| Asthenia |
2.7% |
|
| Interacting |
| Hypertension |
42.9% |
| Addison's Disease |
28.6% |
| Atrial Fibrillation |
14.3% |
| Blood Cholesterol |
14.3% |
|
| Drug Interaction |
50.0% |
| Epistaxis |
50.0% |
|
